Avanos Medical, Inc.

NYSE AVNS

Avanos Medical, Inc. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2024: 3.49%

Avanos Medical, Inc. Return on Capital Employed (ROCE) is 3.49% for the Trailing 12 Months (TTM) ending September 30, 2024, a 147.56% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.
  • Avanos Medical, Inc. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2023 was 1.41%, a -61.99% change year over year.
  • Avanos Medical, Inc. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2022 was 3.71%, a 196.39% change year over year.
  • Avanos Medical, Inc. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2021 was -3.85%, a -2,451.20% change year over year.
  • Avanos Medical, Inc. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2020 was -0.15%, a 95.44% change year over year.
Key data
Date Return on Capital Employed (ROCE) Interest Coverage Ratio Debt to Equity Ratio Return on Common Equity
Market news
Loading...
NYSE: AVNS

Avanos Medical, Inc.

CEO Ms. Mojirade James
IPO Date Oct. 21, 2014
Location United States
Headquarters 5405 Windward Parkway
Employees 3,771
Sector Health Care
Industries
Description

Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Similar companies

SGHT

Sight Sciences, Inc.

USD 3.15

-2.78%

AXGN

AxoGen, Inc.

USD 18.24

-0.06%

SRDX

Surmodics, Inc.

USD 35.55

-0.81%

AORT

Artivion, Inc.

USD 29.68

1.16%

CNMD

CONMED Corporation

USD 67.79

-2.46%

LIVN

LivaNova PLC

USD 47.63

0.66%

NVRO

Nevro Corp.

USD 3.70

-8.19%

ESTA

Establishment Labs Holdings Inc.

USD 33.15

-1.66%

ITGR

Integer Holdings Corporation

USD 138.83

2.72%

KIDS

OrthoPediatrics Corp.

USD 23.55

-5.80%

TMCI

Treace Medical Concepts, Inc.

USD 8.01

-4.19%

FNA

Paragon 28, Inc.

USD 10.28

-4.28%

GKOS

Glaukos Corporation

USD 147.95

-2.58%

OFIX

Orthofix Medical Inc.

USD 17.51

0.81%

ANIK

Anika Therapeutics, Inc.

USD 15.58

-2.14%

StockViz Staff

January 15, 2025

Any question? Send us an email